Oric Pharmaceuticals Liabilities 2024

Oric Pharmaceuticals Aktienanalyse

What does Oric Pharmaceuticals do?

Oric Pharmaceuticals Inc. is a biotechnology company focused on the discovery and development of novel therapeutic approaches for cancer. The company was founded in 2014 by an experienced management team and reputable investors with extensive knowledge in the development and commercialization of cancer drugs. The company is headquartered in Durham, North Carolina, USA. Oric Pharmaceuticals operates a unique business model that focuses on the development of drugs that specifically target cancer cells, thereby increasing therapeutic effectiveness and reducing side effects. The company utilizes a combination of advanced technologies such as genomics, proteomics, and artificial intelligence to develop novel compounds and treatment approaches. The company conducts its research in two business areas: 1) Refinement of the Oric-006 program: The Oric-006 program is a focus of Oric Pharmaceuticals, involving a novel approach to combating cancer. The company has discovered that the protein kinase inhibitor, or Oric-006, is capable of killing tumor cells in patients with advanced tumors. Additionally, the medication is able to slow the spread and inhibit the growth of cancer cells. The company is researching the refinement of Oric-006 and is currently in phase 1b/2 clinical trials. 2) Development of additional compounds: Oric Pharmaceuticals focuses on the development of further therapeutic approaches that can be specifically utilized against specific types of cancer. The company is working on various technologies and platforms to develop new compounds and test their effects against cancer cells. Oric Pharmaceuticals' products have the potential to positively impact the lives of cancer patients and reduce the need for chemotherapy and radiation therapy. The company recognizes the necessity for personalized medicine and utilizes it in the identification of new therapeutic approaches. The company plans to bring its products to market through partnerships and targeted marketing. Oric Pharmaceuticals collaborates closely with experts and leading research institutions for the marketing of their products. Overall, Oric Pharmaceuticals is an innovative company that could play a leading role in the industry due to its focus on personalized cancer medicine and the utilization of cutting-edge technologies. With an experienced management team and reputable investors, the company is positioned for further growth in the future. Oric Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Oric Pharmaceuticals's Liabilities

Oric Pharmaceuticals's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Oric Pharmaceuticals's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Oric Pharmaceuticals's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Oric Pharmaceuticals's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Oric Pharmaceuticals’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Oric Pharmaceuticals stock

What is the level of liabilities of Oric Pharmaceuticals this year?

Oric Pharmaceuticals has a debt balance of 27.92 M USD this year.

What were the liabilities of Oric Pharmaceuticals compared to the previous year?

The liabilities of Oric Pharmaceuticals have increased by 12.58% increased compared to the previous year.

What are the consequences of high debt for investors of Oric Pharmaceuticals?

High liabilities can pose a risk for investors of Oric Pharmaceuticals, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Oric Pharmaceuticals?

Low liabilities mean that Oric Pharmaceuticals has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Oric Pharmaceuticals affect the company?

An increase in liabilities of Oric Pharmaceuticals can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Oric Pharmaceuticals affect the company?

A decrease in the liabilities of Oric Pharmaceuticals can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Oric Pharmaceuticals?

Some factors that can influence the liabilities of Oric Pharmaceuticals include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Oric Pharmaceuticals so important for investors?

The liabilities of Oric Pharmaceuticals are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Oric Pharmaceuticals take to modify the liabilities?

To change its liabilities, Oric Pharmaceuticals can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Oric Pharmaceuticals pay?

Over the past 12 months, Oric Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Oric Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Oric Pharmaceuticals?

The current dividend yield of Oric Pharmaceuticals is .

When does Oric Pharmaceuticals pay dividends?

Oric Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Oric Pharmaceuticals?

Oric Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Oric Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Oric Pharmaceuticals located?

Oric Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Oric Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Oric Pharmaceuticals from 9/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/19/2024.

When did Oric Pharmaceuticals pay the last dividend?

The last dividend was paid out on 9/19/2024.

What was the dividend of Oric Pharmaceuticals in the year 2023?

In the year 2023, Oric Pharmaceuticals distributed 0 USD as dividends.

In which currency does Oric Pharmaceuticals pay out the dividend?

The dividends of Oric Pharmaceuticals are distributed in USD.